Apple acts to avoid U.S. import ban on Apple Watch Series 9 and Ultra 2 over Masimo patent dispute.

Masimo tells appeals court Apple can bypass ban by removing blood oxygen app from affected watches.

U.S. Customs and Border Protection (CBP) says Apple's redesign is outside ITC's ban scope.

Apple asserts redesigned watches definitively lack pulse oximetry functionality.

U.S. Federal Appeals Court to decide on Apple's request to pause ban, possibly by Tuesday.

Masimo applauds Apple's move, emphasizing accountability and respecting intellectual property.

Apple yet to comment publicly on the situation.

U.S. ban imposed in late 2023; ITC ruled blood oxygen sensors violated Masimo's patents.

Apple removed devices before ban, but won appeal to resume sales temporarily.

Apple reportedly working on a software update to distance from Masimo's patented technology.

Modified Series 9 and Ultra 2 smartwatches shipping to Apple Stores; availability uncertain.

Blood oxygen feature expected to continue on sold devices; may remain on watches sold outside the U.S.

Ongoing dispute between Apple and Masimo with many unresolved aspects indicating a long way to go.